We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$3.31B
AUM Growth
-$36.5M
Cap. Flow
-$72.4M
Cap. Flow %
-2.19%
Top 10 Hldgs %
47.35%
Holding
72
New
1
Increased
30
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
CGNT icon
Cognyte Software
CGNT
+$56.1M
2
QDEL icon
QuidelOrtho
QDEL
+$23.1M
3
TW icon
Tradeweb Markets
TW
+$12.1M
4
RBC icon
RBC Bearings
RBC
+$8.3M
5
DXCM icon
DexCom
DXCM
+$5.8M

Sector Composition

Rank Sector Weight
1 Technology 40.39%
2 Healthcare 32.58%
3 Industrials 17.16%
4 Financials 5.5%
5 Consumer Discretionary 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRNT icon
1
Kornit Digital
KRNT
$791M
$241M 7.28%
2,427,805
-179,002
-7% -$17.7M
IDXX icon
2
Idexx Laboratories
IDXX
$46.2B
$209M 6.32%
427,374
-9,284
-2% -$4.65M
AVAV icon
3
AeroVironment
AVAV
$9.45B
$176M 5.32%
1,516,779
-55,882
-4% -$6.53M
FTNT icon
4
Fortinet
FTNT
$117B
$173M 5.23%
4,693,345
-82,675
-2% -$2.7M
MANH icon
5
Manhattan Associates
MANH
$11.4B
$158M 4.78%
1,346,691
+5,016
+0.4% +$607K
ICLR icon
6
Icon
ICLR
$12.7B
$142M 4.3%
724,321
+3,054
+0.4% +$603K
CGNX icon
7
Cognex
CGNX
$11.3B
$129M 3.91%
1,558,090
+3,695
+0.2% +$308K
NICE icon
8
Nice
NICE
$5.97B
$117M 3.55%
538,726
+14,308
+3% +$3.58M
RMD icon
9
ResMed
RMD
$30.7B
$114M 3.45%
588,929
+2,381
+0.4% +$477K
CYBR
10
DELISTED
CyberArk
CYBR
$106M 3.21%
820,164
-2,699
-0.3% -$409K
ANSS
11
DELISTED
Ansys
ANSS
$98.9M 2.99%
291,325
-3,164
-1% -$1.12M
ILMN icon
12
Illumina
ILMN
$28.4B
$94.4M 2.85%
252,589
+1,615
+0.6% +$659K
VEEV icon
13
Veeva Systems
VEEV
$37.4B
$88.7M 2.68%
339,586
-229
-0.1% -$63.8K
FDS icon
14
Factset
FDS
$10.2B
$78.2M 2.36%
253,252
+1,126
+0.4% +$356K
TECH icon
15
Bio-Techne
TECH
$11.3B
$71.6M 2.17%
750,388
+2,868
+0.4% +$262K
ABMD
16
DELISTED
Abiomed Inc
ABMD
$70.5M 2.13%
221,239
+1,566
+0.7% +$501K
QLYS icon
17
Qualys
QLYS
$6.35B
$67M 2.03%
639,650
-2,474
-0.4% -$277K
VRNT
18
DELISTED
Verint Systems
VRNT
$65.9M 1.99%
1,447,726
-1,392,851
-49% -$62.3M
JKHY icon
19
Jack Henry & Associates
JKHY
$11.1B
$65.7M 1.98%
432,724
+24,148
+6% +$3.68M
CSGP icon
20
CoStar Group
CSGP
$12.3B
$58.2M 1.76%
707,910
+9,700
+1% +$837K
GNTX icon
21
Gentex
GNTX
$5.07B
$57.3M 1.73%
1,606,161
+60,885
+4% +$2.16M
RP
22
DELISTED
RealPage, Inc.
RP
$53.9M 1.63%
618,611
-451,027
-42% -$39.2M
CGNT icon
23
Cognyte Software
CGNT
$680M
$52.5M 1.59%
+1,886,540
New +$56.1M
CRL icon
24
Charles River Laboratories
CRL
$12.8B
$50.9M 1.54%
175,500
MEDP icon
25
Medpace
MEDP
$16.5B
$50.6M 1.53%
308,750
+24,418
+9% +$3.73M

Similar funds

American Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, American Capital Management held 72 positions worth $3.31B, down 1.1% from $3.34B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 4.2%. American Capital Management opened 1 new position and exited 2, leaving the 72-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 42% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management's largest Q1 2021 buy was Cognyte Software: 1,886,540 shares worth $52.5M.
  • American Capital Management added most to QuidelOrtho in Q1 2021, an estimated $23.1M increase.
  • American Capital Management's biggest Q1 2021 reduction was Verint Systems, cutting an estimated $62.3M.
  • American Capital Management fully exited Apple in Q1 2021, selling an estimated $307K.
  • American Capital Management's ten largest holdings make up 47% of its $3.31B portfolio in Q1 2021.
  • American Capital Management opened 1 new position and closed 2 in Q1 2021.
  • American Capital Management's portfolio value fell 1.1% quarter-over-quarter to $3.31B.

Based on American Capital Management's 13F filing for Q1 2021, filed 17 May 2021.